News Daily News FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts Michael O'Riordan August 17, 2017
News Daily News Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High Todd Neale July 12, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2017 Shelley Wood June 01, 2017
News Features Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions Michael O'Riordan May 08, 2017
News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017
News Daily News Alirocumab to Remain On Market While Companies Clash Over Patents Michael O'Riordan February 09, 2017
News Daily News FDA’s Latest Move Against Aspirin for CVD Primary Prevention: A Picture Is Worth 11 Words Shelley Wood January 13, 2017
News Daily News Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data L.A. McKeown December 13, 2016
News Daily News Bajo Vigilancia: Cifras Infladas, una Mejor Supervivencia y Pacientes de Menor Riesgo en los Últimos Datos del Registro TVT L.A. McKeown December 13, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2016 Caitlin E. Cox September 01, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes Michael O'Riordan August 12, 2016
News Daily News USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents Michael O'Riordan August 09, 2016
News Daily News FDA: No More Chances for Embattled Coagulation Monitoring System Todd Neale July 13, 2016
News Daily News FDA: No Más Oportunidades para el Acosado Sistema para Monitorizar la Coagulación Todd Neale July 13, 2016
News Daily News Now You See It: FDA Approves Absorb Bioresorbable Scaffold Michael O'Riordan July 05, 2016
News Daily News Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina Michael O'Riordan June 30, 2016